Clinical Trial Update: INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 randomized trial in ovarian cancer completed; no additional details provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED